Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 309

1.

Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort.

Tarricone E, Ghirardello A, Rampudda M, Bassi N, Punzi L, Doria A.

J Immunol Methods. 2012 Oct 31;384(1-2):128-34. doi: 10.1016/j.jim.2012.07.019. Epub 2012 Aug 2.

PMID:
22884621
2.

Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis.

Betteridge ZE, Gunawardena H, Chinoy H, North J, Ollier WE, Cooper RG, McHugh NJ; UK Adult Onset Myositis Immunogenetic Collaboration.

Ann Rheum Dis. 2009 Oct;68(10):1621-5. doi: 10.1136/ard.2008.097162. Epub 2008 Oct 17.

PMID:
18930994
3.

Low prevalence of anti-small ubiquitin-like modifier activating enzyme antibodies in dermatomyositis patients.

Muro Y, Sugiura K, Akiyama M.

Autoimmunity. 2013 Jun;46(4):279-84. doi: 10.3109/08916934.2012.755958. Epub 2013 Feb 8.

PMID:
23215730
4.

Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.

Hengstman GJ, Brouwer R, Egberts WT, Seelig HP, Jongen PJ, van Venrooij WJ, van Engelen BG.

J Neurol. 2002 Jan;249(1):69-75.

PMID:
11954871
6.

Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase.

Hirakata M, Suwa A, Takada T, Sato S, Nagai S, Genth E, Song YW, Mimori T, Targoff IN.

Arthritis Rheum. 2007 Apr;56(4):1295-303.

7.

Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies.

Krystufková O, Vallerskog T, Helmers SB, Mann H, Putová I, Belácek J, Malmström V, Trollmo C, Vencovsky J, Lundberg IE.

Ann Rheum Dis. 2009 Jun;68(6):836-43. doi: 10.1136/ard.2008.091405. Epub 2008 Jul 15.

PMID:
18628284
8.

Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort.

Bodoki L, Nagy-Vincze M, Griger Z, Betteridge Z, Szöllősi L, Dankó K.

Autoimmun Rev. 2014 Dec;13(12):1211-9. doi: 10.1016/j.autrev.2014.08.011. Epub 2014 Aug 23. Review.

PMID:
25182203
9.

A novel autoantibody to a 155-kd protein is associated with dermatomyositis.

Targoff IN, Mamyrova G, Trieu EP, Perurena O, Koneru B, O'Hanlon TP, Miller FW, Rider LG; Childhood Myositis Heterogeneity Study Group; International Myositis Collaborative Study Group.

Arthritis Rheum. 2006 Nov;54(11):3682-9.

10.
11.

[How can we diagnose and better understand inflammatory myopathies? The usefulness of auto-antibodies].

Sibilia J, Chatelus E, Meyer A, Gottenberg JE, Sordet C, Goetz J.

Presse Med. 2010 Oct;39(10):1010-25. doi: 10.1016/j.lpm.2010.06.008. Epub 2010 Jul 23. French.

PMID:
20655695
12.
13.

Establishment of an ELISA to detect anti-glycyl-tRNA synthetase antibody (anti-EJ), a serological marker of dermatomyositis/polymyositis and interstitial lung disease.

Hane H, Muro Y, Watanabe K, Ogawa Y, Sugiura K, Akiyama M.

Clin Chim Acta. 2014 Apr 20;431:9-14. doi: 10.1016/j.cca.2014.01.005. Epub 2014 Feb 5.

PMID:
24508626
14.

Antibodies to glycyl-transfer RNA synthetase in patients with myositis and interstitial lung disease.

Targoff IN, Trieu EP, Plotz PH, Miller FW.

Arthritis Rheum. 1992 Jul;35(7):821-30.

PMID:
1622421
15.

[Myositis-specific autoantibodies].

Fujimoto M.

Brain Nerve. 2013 Apr;65(4):449-60. Review. Japanese.

PMID:
23568993
16.

Association of distinct clinical subsets with myositis-specific autoantibodies towards anti-155/140-kDa polypeptides, anti-140-kDa polypeptides, and anti-aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single-centre, cross-sectional study.

Fujikawa K, Kawakami A, Kaji K, Fujimoto M, Kawashiri S, Iwamoto N, Aramaki T, Ichinose K, Tamai M, Kamachi M, Nakamura H, Ida H, Origuchi T, Ishimoto H, Mukae H, Kuwana M, Kohno S, Takehara K, Sato S, Eguchi K.

Scand J Rheumatol. 2009;38(4):263-7. doi: 10.1080/03009740802687455.

PMID:
19444719
17.

The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis.

Chinoy H, Fertig N, Oddis CV, Ollier WE, Cooper RG.

Ann Rheum Dis. 2007 Oct;66(10):1345-9. Epub 2007 Mar 28.

18.

Clinical features of anti-TIF1-α antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-γ or anti-Mi-2 autoantibodies.

Muro Y, Ishikawa A, Sugiura K, Akiyama M.

Rheumatology (Oxford). 2012 Aug;51(8):1508-13. doi: 10.1093/rheumatology/kes073. Epub 2012 Apr 25.

19.

Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients.

Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y, Senécal JL.

Medicine (Baltimore). 2005 Jul;84(4):231-49.

20.

Idiopathic inflammatory myopathy: autoantibody update.

Targoff IN.

Curr Rheumatol Rep. 2002 Oct;4(5):434-41. Review.

PMID:
12217249
Items per page

Supplemental Content

Write to the Help Desk